Graphene quantum dots (GQDs) maintain the intrinsic layered structural motif of graphene but with smaller lateral size and abundant periphery carboxylic groups, and are more compatible with biological system, thus are promising nanomaterials for therapeutic applications. Here we show that GQDs have a superb ability in drug delivery and anti-cancer activity boost without any pre-modification due to their unique structural properties. They could efficiently deliver doxorubicin (DOX) to the nucleus through DOX/GQD conjugates, because the conjugates assume different cellular and nuclear internalization pathways comparing to free DOX. Also, the conjugates could enhance DNA cleavage activity of DOX markedly. This enhancement combining with efficient nuclear delivery improved cytotoxicity of DOX dramatically. Furthermore, the DOX/GQD conjugates could also increase the nuclear uptake and cytotoxicity of DOX to drug-resistant cancer cells indicating that the conjugates may be capable to increase chemotherapy efficacy of anti-cancer drugs that are suboptimal due to the drug resistance. N anomaterials, due to their unique nanoarchitectures and diverse properties offer an unprecedented opportunity for improving drug loading, targeting, and efficacy 1,2 . To this end, various nanostructured materials, such as carbon nanotubes 3 , polymeric nanoconjugates 4, 5 , nanoparticles etc. 6, 7 have been explored, especially in cancer therapy. However, the delivery of the anti-cancer drugs to the nucleus by nanostructured materials remains a significant challenge [8] [9] [10] [11] . Engineering the surfaces of nanomaterials with nucleartargeted peptide, or chemicals could enhance the nuclear uptake and cytotoxicity of the drugs, but the modification dramatically increases the complexity in vivo, such as opsonization, and difficulty for preparation and application [12] [13] [14] . Recently, there has been significant biomedical research interest in graphene and graphene oxide (GO) because of their single atomic-layered structure and chemical properties [15] [16] [17] . Their therapeutic applications harnessed the opportunities that provided by graphene and GO to improve the drugs solubility 18 , extend their half-life 19, 20 , and to reduce their side effects 21, 22 . For instances, Dai et al pioneered the research in this area that PEG modified GO could increase the aqueous solubility of the anti-cancer drugs 23 . Zhang et al modified nano-scaled GO with folic acid (FA) then loaded the mixed anti-cancer drugs to specifically target the cells with FA receptors 24 . In most work so far reported, the drug loading on the pre-modified graphene or GO sheets was through hydrophobic and p-p stacking, but the release of anti-cancer drug was pH responsive 21, 22 . And in most cases, the cytotoxicity was increased by the graphene or GO based delivery systems, but there is no experimental evidence showing that the accumulation of the anti-cancer drugs in the nucleus was improved, which makes their functional mechanisms are unclear. Moreover, graphene or GO sheets have been almost exclusively employed as drug carriers using their single atomic-layered structural feature, the intrinsic biological function of graphene, GO or their derivatives is ignored.
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In our previous work, we found that GO sheets combining with copper ions could cleave the plasmid DNA into nicked DNA suggesting that GO sheets could be potentially useful in anti-cancer therapy 25 . Inspired by that finding, we further explored the impact of the GO on the small chemical nucleases, and found that the nuclease activity and cytotoxicity of the chemical nucleases were both enhanced markedly upon combining with GO sheets 26 . These findings and other complimentary results lead us to believe that a conjugate of GO/chemical nucleases results in an improved nuclease activity and cytotoxicity 26 . These results imply that GO is a potentially ideal nanomaterial for improving the efficacy of anti-cancer drugs that function through intercalating to nucleic acid. In addition to that, we also found that the lateral dimension of GO sheets is a critical factor for the cleavage activity of GO/Cu 21 system. This is expected because the diameter of normal B-DNA helix is much smaller comparing to the GO sheets with the lateral size range from several nanometer to micrometer. Possibly only those GO sheets with the comparable size to DNA interact with it. We, hence, developed recently a facile preparation method of graphene quantum dots (GQDs) with periphery carboxylic groups and average lateral size of ,30 nm or even smaller. Due to their unique structural property, the as-prepared GQDs dispersed very well in aqueous solution. Combining with copper ions, GQDs exhibited several folds higher DNA cleavage activity than that of GO 27 . Therefore, we foresee that the GQDs might improve the nuclease activity of the chemical nucleases. Figure 1a compared the DNA cleavage activity enhancements by GQDs (average lateral size, ,20 nm) and GO to a classical chemical nuclease, di-1,10-phenanthroline-copper (Cu(phen) 2 ). It was well known that increasing the aromatic plane of Cu(phen) 2 could improve its DNA cleavage activity through increasing its affinity to DNA 28 . As expected, under the same reaction conditions, the supercoiled plasmid DNA (Band I) can be cleaved more completely in the presence of the GQDs than that of GO (lane 2 vs lane 10). At a high concentration of GQDs, not only nicked DNA (Band II), linear DNA (Band III) were also generated; whereas for GO, only nicked DNA fragments were observed (lanes 7-12 vs lanes 1-6). Additionally, no DNA samples dwelled in the sample wells in the case of GQDs even at a higher concentration indicates that GQDs also have a better size consistence and biocompatibility 27 . On the basis of the aforementioned results, we hypothesize that GQDs will show high potency in cancer therapy than GO. The assumption is examined systematically in this work using an anticancer drug doxorubicin (DOX). The interaction of GQD with DOX, cellular internalization, cellular distribution, and cytotoxicity of the GQDs, and potential application in drug-resistant cells were investigated. We found that without any pre-modification, GQDs not only can efficiently accelerate DOX nuclear accumulation, but also enhance markedly the DNA cleavage activity and cytotoxicity of DOX, which are superior to the modified graphene or GO and many nanoparticle-based DOX delivery systems [8] [9] [10] [11] .
Results
Enhanced DNA cleavage activity of DOX by the GQDs. To discover the potential of the GQDs in anti-cancer therapeutics, the effect of GQDs on the DNA cleavage of DOX was explored initially. DOX is one of the most commonly used anti-cancer chemotherapeutics, but its clinical utility is limited by low solubility and severe side effects 29 . The cytotoxicity of DOX is associated with its intercalation between two base-pairs of DNA in the nucleus to form DNA adduct or DNA cross-linking inducing interference with DNA strand separation and DNA helicase 30 . DOX is also believed to be reduced to a semiquinone radical inside cell, which is generated in electron-transfer chains and induces the formation of highly reactive hydroxyl radicals that capable of cleaving DNA molecules 31, 32 . Figure 1b shows that at a low concentration of GQDs, the DNA cleavage by DOX is barely affected; at about 60 mg mL 21 of GQDs, the percentage of nicked DNA fragment starts to increase, and cleavage activity is improved and reaches the maximum with 150 mg mL 21 of GQDs, further increasing of the GQDs concentration results in a decline in the cleavage activity. It was also noticed that the DNA cleavage enhancement by GQDs is time dependent. Increasing the incubation time, the cleavage is more complete as shown in Figure S1 . In the presence of 150 mg mL 21 of GQDs, after 2 h of incubation, the plasmid DNA can be cleaved completely into nicked (98%) and linear (2%) DNA fragments. The time and concentration dependent cleavage phenomena unambiguously show that the GQDs can enhance DNA double strand breaks. Noticeably, the activity enhancement is critically dependent on the ratio between GQD and DOX. This observation is analogous to the behavior of the GO/chemical nuclease conjugates 26 , suggesting that GQDs possibly work together with DOX molecules.
Formation of DOX and GQD conjugates (DOX/GQD). To explore the state of the DOX and GQD in solution, the electronic and fluorescence properties of DOX were employed to monitor their interactions. Figure 2a depicted the changes in the UV-vis spectrum of DOX in the presence of different amount of GQD. Decrease of the peak intensity at 490 nm that ascribed to the p-p transitions of electrons of the aromatic rings of DOX with the increase of the concentration of GQD suggests that a p-p interaction occurred between the GQD and DOX as observed for the interaction between GO and DOX 24 , because the GQD assumes a planar structure with peripheral carboxylic groups that is similar to GO. Apparent binding constant (K b , 0.013 mg mL 21 ) of the DOX to GQD obtained using the previously published procedure 33 was smaller compared to the binding constants of the chemical nuclases to GO, possibly because the electrostatic interaction contributed less in the case of GQDs 27 . Nevertheless, the results suggested that GQDs and DOX molecules formed conjugates in solution. To verify the conjugation state of the DOX with GQD, the fluorescence of DOX was monitored in the presence of different amount of GQDs. It was reported that the fluorescence of small molecules can be quenched by the GO because of their p-p stacking with GO 23, 34 . Hence the change of the fluorescence of DOX can be used to monitor its interaction with GQDs. As expected, the fluorescence intensity of DOX decreased with the increase of the concentration of GQDs, and was mostly quenched at DOX to GQD ratio of ,0.04 (mg to mg) ( Figure 2b ). Most noticeably, this ratio was consistent with the ratio, at which the DNA cleavage activity of DOX was enhanced maximally (Figure 1b ). The ratio thus was used hereafter to prepare DOX/GQD conjugates assuming that there is no free DOX under this condition. The conjugation state was also confirmed by their AFM images as shown in Figure S2 . The thickness of the GQDs is obviously increased from ,1 nm to ,3 nm when forming DOX/GQD conjugates. The formation of the conjugates was also supported by the changes in the zeta potential of the GQDs in the presence of DOX ( Figure S3 ). The stability of the DOX/GQD conjugate was tested for different storage time, and in the buffers with different pH values and ionic strengths. The conjugates are stable at room temperature for 36 h in PBS buffer or cellular culture medium ( Figure S4a , b), no changes occurred in the solutions with different ionic strengths neither ( Figure S4c ), just a slight fluorescence variation in the solutions from pH 2 to 7.4 was observed ( Figure S4d) . The later is different from that of the DOX/GO system, in which ,70% DOX could be released at pH 2 after 24 h 35 . On the basis of these results, a molecular model of the DOX/GQD conjugate was built as shown in Figure S5 . The high stability of the DOX/GQD conjugates further supports that the interaction between GQD and DOX is mainly contributed by p-p stacking. This conclusion was solidified complementarily by the complete release of DOX from GQDs in 50% ethanol as shown in Figure S5 .
Enhance cytotoxicity of DOX by GQDs. The high stability of the DOX/GQD conjugates implies that the function of GQDs in the interaction of DOX with DNA molecules is similar to GO/ chemical nuclease systems 27 . The GQDs increased the binding affinity of DOX to DNA, eventually improved its DNA cleavage activity. It is well known that DNA cleavage by DOX and its derivatives normally results in an enhanced cytotoxic potency 36 . In attempt to understand whether the enhancement in DNA cleavage activity of DOX by GQDs is correlated to cytotoxicity, the impact of DOX/GQD conjugates on the cytotoxicity of DOX to human breast cancer cells MCF-7 and kidney cancer cells MGC-803 was studied. DOX alone exhibits cytotoxicity to both MCF-7 and MGC-803 cells, insets in Figures 2c, and S6, as reported in the literature 37, 38 . The GQDs alone under the same conditions showed very low toxicity to both cell lines ( Figure S7 ) 39 . In the presence of GQDs, cytotoxicity of DOX to both cell lines was enhanced,which was increased with the increase of the concentration of GQDs (Figures 2c, and S6 ). In the case of MCF-7, the cell viability was dropped from 58% to 35% with the presence of 50 mg mL 21 of GQDs. The viability was then slightly lowered with the further increase of GQDs concentration. Similar to MCF-7 cells, the cell viability of MGC-803 cells lines also decreased noticeably starting from 50 mg mL 21 of GQDs. Further increase of the GQDs, the cytotoxicity maintains unchanged. The improved cell killing in the presence of GQDs is consistent with the observation for the DOX derivatives, in which high DNA cleavage activity corresponds to an increased cytotoxic potency 36 . Though the correlation of the DNA cleavage activity with the cytotoxicity was actually reported for the anti-cancer drugs encapsulated in polymer-lipid hybrid nanoparticle 40 , it is necessary to clarify the intracellular distribution of the DOX/GQD conjugates first to solidify the result.
Effects of GQDs on the cellular uptake and intracellular distribution of DOX. Although the DOX/GQD conjugates are stable in cell culture media (Figure S4 ), the status of the DOX/GQD conjugates inside the cell is still a key issue that needs to be illustrated in order to correlate their nuclease activity and cytotoxicity. To understand this question, confocal laser scanning microscopy (CLSM) images of the cells incubated with DOX, GQDs, and DOX/GQDs for different incubation times were taken, respectively, as shown in Figure 3 . The impact of the DOX/GQD conjugates is compared with the free DOX and GQDs in terms of the fluorescence intensity and distribution. Fluorescence intensity of the as-prepared GQDs is relative weak 27 , and also the fluorescence emission wavelength of GQDs overlaps with the cellular auto fluorescence, thus the red fluorescence of DOX was monitored instead. With the incubation time increasing from 4 to 24 h (comparing vertically in Figure 3) , the fluorescence intensity of the cells with GQDs alone was barely increased. The fluorescence of the cells with DOX alone increases with the incubation time, and DOX molecules gradually diffuse into nuclei after 24 h of incubation, consistent with the results in the literature 10, 12 . Noticeably, the fluorescence of the cells incubated with DOX/GQD conjugates for 4 h originates exclusively from the nuclei. Almost no fluorescence was observed in the cytoplasm, indicating that free DOX molecules solely located inside the nucleus under this condition. In addition, the fluorescence intensity of the cells that incubated with DOX/GQD is about two folds higher than that of the cells incubated with DOX alone under the same concentration (right column in Figure 3 and Figure S8 ). The rapid nuclear uptake and stronger fluorescence intensity in the nuclei reveal undoubtedly that DOX/GQD conjugates increase the rate and amount of the DOX nuclear accumulation. To further confirm the result, the nuclei were stained with Hoechst and the images were overlapped with the DOX fluorescence images as shown in Figure  S9 . The overlays (panel d in Figure S9 ) of the stained nuclei, DOX, and the bright field images clearly corroborate the result that DOX accumulation occurs in the nucleus solely in the presence of GQDs. Remarkably, the enhancement on the DOX penetration into nuclei is also dependent on the concentration of GQDs, higher concentration of GQDs is favorable to the DOX nuclear uptake (panel c in Figure S9 , comparing horizontally).
The nuclear accumulation enhancement by GQDs was further proved by flow cytometry, in which the cellular uptake of DOX under different conditions can be compared quantitatively. Figure 4 displayed the cellular uptakes of the DOX alone and DOX/GQD conjugates incubated for 1 and 4 h, respectively. With a short incubation time (1 h, top panel in Figure 4 ), cytometric profiles clearly indicated that fluorescence intensity of the cells with the DOX/GQD conjugates is stronger (red peak) than that with DOX alone (blue peak), which is consistent with the corresponding CLSM images on the right. With the incubation time increase up to 4 h, more DOX molecules were accumulated inside the cell in both cases, and the difference in the total fluorescence intensity between the two samples is getting smaller with a longer incubation time. However, for the cells incubated with DOX, the fluorescence intensity is generated by the DOX distributed both in the cytoplasm and nucleus of the cells. While for the cells incubated with the DOX/GQD conjugates, the total fluorescence intensity is from the DOX molecules that are inside nuclei only. Hence, even the fluorescence intensities of the cells incubated with DOX alone or DOX/GQD conjugates are comparable after the longer incubation time, the nuclear accumulation of DOX is still higher with DOX/GQD conjugates than DOX alone. The results collectively showed that under the same DOX concentration, the GQDs dramatically enhanced DOX nuclear uptake. This finding is therapeutically more important than the enhanced intracellular uptake. In fact, in many anti-cancer nanodrug systems, cellular uptake of the drugs was usually improved, but few of them could enhance the drug nuclear uptake without nuclear-targeted modification [8] [9] [10] [11] . In addition, the results may be practically important to reduce the side effects imposed by the high dose of anti-cancer drugs.
Cellular internalization and functional mechanism of the DOX/ GQD conjugates. Generally, cells uptake exogenous materials such as nanoparticles through endocytosis 41, 42 . We previously found that both energy-independent and energy-dependent pathways are possibly involved in the GQDs cellular uptake, and caveolaemediated endocytosis may be the primary pathway 39 . Figure S10 showed the fluorescence images of the cells that were pretreated with different inhibitors of various endocytotic mechanisms including chlorpromazine, filipin III, and NaN 3 , and then incubated with the DOX/GQD conjugates for 4 h. The fluorescence intensities of the cells pretreated with three inhibitors are all weakened with different extents, and among them chlorpromazine seems relatively more effective as shown in panels b and d in Figure  S10 . The results indicate that energy-dependent endocytosis, clathrin-mediated endocytosis, and caveolae-mediated endocytosis are all likely involved in the cellular uptake of the DOX/GQD conjugates. Multiple endocytotic pathways may contribute partially to the efficient cellular uptake of DOX via DOX/GQD conjugates.
Through endocytosis, cells eventually route some exogenic materials towards lysosomes where the enzymes will degrade them to protect cells. As showed in Figure S4 , the DOX/GQD conjugates is very stable from pH 2-10, suggesting that pH trigged DOX release is unlikely to occur in acidic lysosome 43, 44 . The release of DOX from the DOX/GQDs conjugates may take place in a hydrophobic environment, because the fluorescence of DOX that quenched by GQDs can be completely recovered when adding 50% ethanol ( Figure S5) . However, such strong hydrophobic environment is generally unlikely existed inside cells. It was well known that the particles that are smaller than ,10 nm can freely diffuse into the nucleus 45 . Owing to the inherent flexibility and small size of the GQDs, it is very likely DOX/GQD conjugates penetrate the nucleus by diffusion. DNApolylysine complexes as large as ,60 nm were shown to efficiently deliver DNA to the nucleus, in which it was believed that the larger structures were able to pass through the nuclear pores owing to the inherent flexibility of the conjugate 46 . Hence, we postulate that the release of DOX from the DOX/GQD conjugates occur inside the nucleus when they interact with DNA molecules. This hypothesis is consistent with the observation in the fluorescence microscopy images. No fluorescence of DOX was observed in the cytoplasm in the presence of GQDs (Figures 3, 4 , and S9) indicates that DOX molecules exist as DOX/GQD conjugates in the cytoplasm, because the fluorescence of DOX will be quenched by GQDs when they bind together (Figure 2b) . The strong fluorescence intensity of DOX displayed in the nuclei when the cells incubated with DOX/GQDs even for a shorter incubation time (1 h in Figure 4 ), confirmed that DOX separated from GQDs in the nucleus. The release of DOX from the DOX/GQD conjugates in the nucleus was also supported by the DOX efflux experiment. Figure S11 showed the fluorescence microscopy images of the cells incubated with the DOX/GQDs first, then continuously incubated with fresh media without GQD or DOX. With a longer incubation time, DOX molecules start to diffuse to the cytoplasm, indicating the DOX molecules that entered as the DOX/GQD conjugates are free in the nuclei. We also found that once DOX binds to DNA, they would not bind to the GQD anymore. (Figure S12 ). The detachment of DOX from the DOX/GQD conjugates in nucleus was also strongly supported by the fluorescence diminish of the pre-stained nuclei after the incubation with GQDs as shown in Figure 5 . With the concentration of GQDs increase, the fluorescence of nuclei gradually decreased. This could be caused either by the disruption of the interaction between the dye and DNA, or fluorescence was quenched by GQDs directly. Nevertheless, the result revealed unanimously that GQDs entered into the nuclei. Taken all these results together, the cellular and nuclear uptake mechanism of the DOX/GQDs was schematically summarized in Figure 6 . The DOX/GQD conjugates entered the cell through clathrin-mediated and caveolae-mediated endocytosis, then were routed to lysosomes or Golgi before diffusing into nucleus 39 . The release of DOX from the conjugates occurs inside nucleus driven by the higher affinity of DOX/GQDs towards DNA molecules, though it is hard to detect the DOX binding to DNA in cell nuclei 47 . Our data, although not sufficient to directly support every step of this process, are consistent with such an interpretation. The release mechanism of the DOX from DOX/GQD conjugate in vivo requires further investigation.
Discussion
The superb performance of the DOX/GQD conjugates in targeted drug delivery, DNA cleavage, and cytotoxicity to MCF-7 cells suggests that the conjugates may be capable of suppressing the cellular resistance to DOX. As one of the generally accepted drug-resistant mechanisms is that the membrane bound active drug efflux pumps are over expressed in many drug-resistant cells 48, 49 . Bypassing these transporters via DOX/GQD conjugates can therefore possibly avoid the DOX resistance. To test this hypothesis, the cellular penetration of GQDs alone to the DOX resistant cells MCF-7/ADR that were exposed to a low dose of DOX (1 mM), was first tested ( Figure S13 ). The GQDs can easily enter the MCF-7/ADR cells as indicated by the quenched fluorescence of DOX in the cytoplasm. However, the entered DOX molecules only dwell in the cytoplasm, even with a higher DOX concentration ( Figure 7 , DOX column) that agreed with the literature data ( Figure 7 , control column) 50, 51 . When the MCF-7/ ADR cells were incubated with the DOX/GQD conjugates, remarkably, instead of residing in the cytoplasm, DOX penetrates into the nuclei (Figure 7 , Top part, DOX/GQD column). The results are more obvious when the images are overlapped with the bright field images, the Hoechest dyed nuclear image, and DOX fluorescence as shown in the panel d of Figure 7 . This nuclear penetration is in accordance with the cytotoxicity enhancement of the DOX/GQDs to MCF-7/ ADR cells as shown in the bottom part of Figure 7 . Under the constant GQD concentration, the cytotoxicity of DOX/GQDs to MCF-7/ ADR cells is higher than that of free DOX (red line versus black line) indicating DOX was efficiently delivered to the drug resistant cells by DOX/GQD conjugates. We also observed that at a low DOX concentration, the growth of the MCF-7/ADR cells was enhanced by DOX alone, but not by DOX/GQD conjugates. Overall, this preliminary data of the drug resistant cells validates our results performed on the wild type cancer cells. More importantly, the result suggests it is possible to overcome drug resistance in tumor cells using DOX/ GQD conjugates.
In summary, we demonstrate that the GQDs possess dual function as a targeted anti-cancer drug carrier and DNA cleavage activity enhancer, which should be potentially useful in cancer therapy. The GQDs interact with DOX forming stable conjugates, which deliver their cargo to the nucleus specifically and simultaneously improve the DNA cleavage activity of DOX. The enhancement of the GQDs on the DNA cleavage activity and nuclear accumulation of DOX lead to its higher cytotoxicity both to wild type and drugresistant cancer cells. The results are encouraging, this is the type of nanomaterials that could accelerate efficiently the nuclear accumulation of the anti-cancer drug and simultaneously enhance the anti-tumor efficacy of the drug without any pre-modification with chemicals or biological molecules. The results are practically important, the GQD conjugates might be used to increase chemotherapy efficacy, to reduce the side effects imposed by the high dose of anticancer drugs, and more significantly to improve suboptimal therapeutic response of the anti-cancer drugs that associated with the drug resistance.
Methods
General information. DOX was purchased from Aladdin Chemistry Co. Ltd. Supercoiled PSICOR-GFP DNA plasmid was purified from DH5a cells using an Endo Free Plasmid Kit (QIAGEN, USA). All other chemicals and reagents were purchased from Sino Pharm Chemical Reagent Co. Ltd. in analytic grade and were used as received.
Agarose gel electrophoresis was carried out with a DYY-6C electrophoresis apparatus (Liuyi Instrumental Co., China). The agarose gels were visualized and digitized with the FR-200A gel image analysis system and analyzed by Smart View software. The UV-vis measurements were performed on a Cary 50 spectrometer (Varian, USA). The fluorescence spectra were acquired by a Cary Eclipse spectrofluorometer (Varian, USA). Fluorescence images of cells were obtained by a fluorescence microscopy (Nikon ECLIPSE, Ti-S) and A1R confocal laser scanning microscope (Nikon, Japan). Flow cytometry was performed on FACS Calibur (BD Biosciences, Mountain View, CA).
GQDs preparation and characterization. The GQDs were prepared through photoFenton reactions of graphene oxide as described in our previous work 27 . The photoFenton reactions were carried out in a quartz tube with graphene oxide and Fenton reagent, FeCl 3 and H 2 O 2 mixture under vigorous stirring in a photo reactor and initiated by a mercury lamp (365 nm, 1000 W) (Bilon, Shanghai). The pH of the mixture was adjusted to 4. The reaction products were dialyzed in ultrapure water for two days to remove reactants and small product molecules. The generated GQDs were characterized by AFM, XPS, TEM, and FT-IR, UV-visible, and Florescence spectroscopies. The aqueous suspension of GQD was stored at room temperature, and sonicated, filtered with a sterilized 0.22 mm filter prior to use.
DNA cleavage experiments. DNA cleavage activity of DOX was studied by agarose gel electrophoresis. Excess and freshly prepared NaBH 4 solution was used as reducing agent 32 . Reactions were carried out in sodium phosphate buffer (50 mM, pH 7.0). The DNA plasmid was incubated with different concentration of DOX and GQD at 37uC, quenched by addition of the loading buffer (0.05% bromophenol blue, 1% SDS, and 50% glycerol). The mixture was then subjected to electrophoresis on a 0.5% agarose gel containing ethidum bromide (0.5 mg mL 21 ) in TBE buffer at 90 V for approximately 1 h 25, 26 .
Binding measurements of DOX to GQD. DOX and GQD aqueous solutions were mixed sufficiently and incubated for 5 min in dark; the UV-vis absorption of the mixture was then recorded. The binding constant of DOX to GQD was calculated according to the previously published method 33 . Fluorescence spectroscopy was also employed to investigate the interaction of DOX with GQD. Fluorescence spectrum of DOX were recorded by using an excitation wavelength of 500 nm with the increased concentrations of GQD. ADR (purchased from Ruizhi Bio-pharmaceutical Technology Co., Ltd) were cultured under the same condition, except for with 1 mM of DOX to maintain their drug resistance.
Fluorescence microscopy and confocal laser scanning microscopy. MCF-7 cells were detached by trypsin and plated on the collagen coated W14 mm cover slips at a density of 5 3 10 4 cells per well in 24-well plates to culture sequentially. After 12 h of attaching, the medium was replaced with the medium without serum but containing 1 mM of DOX or 1 mM of DOX with 150 mg mL 21 of GQD followed by the washing with PBS buffer two times. For comparison the control cells were incubated in the fresh medium without serum. After incubation for different time, the cells were washed two times with PBS buffer to remove free drug and GQDs and then fixed with 4% paraformaldehyde (pH 5 7.4). After 15 min for fixing, the paraformaldehyde was removed 10 . The cells were washed two times with PBS buffer to remove the residual fixing reagent. To stain the nuclei, 300 mL of Hoechst PBS solution (0.5 mg mL
21
) was added at this stage, and incubated for 5 min 7 . The coverslips were laid onto slides after washing with PBS buffer. The prepared slides were imaged by fluorescence microscope or confocal laser scanning microscope.
Cytotoxicity assay. The viability of MCF-7 and MGC-803 cells in the presence of DOX or DOX/GQDs was assayed using MTT assay kit (Beyotime Institute of Biotechnology, China). Cells were plated in a 96 well microplate at a density of 4000-5000 cells. Background control wells containing the same volume of complete culture medium were included in each assay. The microplate was incubated for 24 h at 37uC. Then the cells were washed with PBS buffer and incubated with DOX and GQDs in serum-free medium, and the plate was incubated further for 24 h. The optical density of DMSO solution of formazan at 490 nm was recorded after 4 h of incubation with MTT 12 .
Flow cytometry measurement. To obtain a quantitative cellular uptake of DOX in the presence of GQDs, MCF-7 cells were cultured with DOX or DOX/GQD in a 6-well plate at the density of 5 3 10 5 cells per well for different time. The cells were then washed with PBS three times and harvested. The cells were re-suspended in PBS buffer (10 mM) and fixed with cold 70% ethanol aqueous solution overnight for flow cytometric measurement 51 .
